Here is my prediction for Quest Diagnostics (DGX), a healthcare company. The forecast is using deseasoned operating income data with a high regression manifest. The trend is for operating income to grow at a slowing rate, which is not good for the company's share price. Initial reports call for a price of 38.67 in one year--a near 24% drop. Therefore, last week's analysis of LabCorp seems to be a better company to invest for this industry.

Recommendation: Sell